Product Code: GC-0131F045-0000

$274.05 inc GST In Stock Low Stock Out Of Stock Please See Attributes

Increase value Decrease value

Quantity In Cart:

Description

For high caries risk and special needs patients. Contains 900ppm fluoride in addition to bio-available calcium and phosphate in the appropriate ratio for remineralization of tooth structure. Suitable for patients with active caries, white spot lesions, pregnant mothers, during and after orthodontics, desensitizing, medically compromised patients, patients with an acidic oral environment, patients with erosion and gastric reflux, patients with poor plaque control, high caries risk patients and to provide extra protection for teeth.

Instructions for Using GC Tooth Mousse/Plus:

1. After brushing your teeth, dispense a small amount of GC Tooth Mousse/Plus onto a clean finger.
2. Gently apply the product to all teeth using the finger and evenly distribute with your tongue.
3. Allow GC Tooth Mousse/Plus to remain on your teeth for a minimum of three minutes, avoiding swallowing and spitting.
4. For optimal results, leave the product in contact with your saliva for an additional 1-2 minutes.
5. Spit out any excess product.
6. Do not rinse your mouth, eat, or drink for 30 minutes after applying GC Tooth Mousse/Plus. Any residual product on your teeth will eventually dissipate on its own.

Always read the label and follow the directions for use. If symptoms persist, talk to your healthcare professional.

GC Tooth Mousse Plus and GC Tooth Mousse contain RECALDENT (CPP-ACP) which is derived from cow's milk. GC Tooth Mousse Plus also contains hydroxybenzoates and soybean products. Do not use this product if you have a suspected or proven allergy to milk proteins, benzoate preservatives or soybean derivative. In case of an allergic reaction: stop use, rinse mouth with water and seek medical advice. Contains soybean derived products. RECALDENT and RECALDENT logo are trademarks of Mondelēz International group used under license. CPP-ACP technology has related patents or patents pending in Australia, New Zealand, Europe, Canada, and USA.